Did anti-GMO groups plant ‘rogue’ GMO wheat in Canada to deliberately disrupt markets to manipulate public opinion?

wheat seeds

In the summer of 2017, a contractor applied the popular weed-killer glyphosate (brand name Roundup®) to clear some weeds along an oil and gas service road. (Glyphosate is a very effective herbicide that controls hundreds of different weeds.) When wheat plants did not die after the contractor applied the herbicide, he contacted the authorities. 

The Alberta government determined the wheat was an herbicide-tolerant variety that had been genetically engineered (GE) with molecular techniques. GE wheat had been field-tested (not in recent years, however), but no developer has ever applied for or received regulatory approval for cultivation or sale of a GE wheat variety in Canada or the United States. 

Detailed investigation by the Canadian Food Inspection Agency (CFIA) uncovered some very strange facts. The GE wheat found in Alberta contained the same herbicide-tolerance (HT) gene (designated MON71200) that was field tested by the Monsanto Company (now Bayer) between 1998 and 2000, but those field trials were no closer than 180 miles from where the sample was found. 

Most puzzling to the investigators, however, was that the genetics of the newly found wheat plant itself not only didn’t match any of the approximately 450 registered varieties of wheat allowed to be grown in Canada, but it didn’t match any wheat plant anywhere of which the Canadian authorities were aware. 

roundup777446353
Image Credit: Mike Mozart / Flickr

Could the newly discovered GE wheat have escaped from a field trial and survived for nearly two decades? The findings of the CFIA don’t support that thesis.

The registered field trials with wheat containing the MON71200 gene were discontinued in 2000 as the company moved to newer, more effective HT genes. This means that the HT gene found in 2017 was either stored somewhere or propagated in the wild for 17 years before it was discovered on the roadside in Alberta. The official field trials were far away, so local escape of the GE wheat is not a realistic possibility. That’s strike one for the inadvertent-contamination theory.

Alberta winters are very cold, and exposed wheat seed is unlikely to survive well and spread. Still, if it was propagating in the wild for all that time, there should be many instances of it showing up in Canadian wheat crops, but the CFIA examined more than 170,000 samples spanning several years and found exactly zero that contained the MON71200 gene. 

Even if the herbicide tolerance gene did come from the original field trials, we are still left with the question, how did it naturally move into a new variety of wheat that does not exist in Canada? That’s strike two for the inadvertent-contamination theory.

The Alberta farmer on whose land the GE wheat variety was found never took part in the original field trials and when tested, his farm — fields, equipment and buildings — was completely free of the herbicide-tolerance gene.

Neither did this unknown wheat variety match the GE wheat used in U.S. field trials, so the “rogue” Canadian GE wheat could not possibly have escaped from any field trial in North America. Strike three for the inadvertent-contamination theory.

That brings us back to the basic question: How did a few stalks of GE wheat whose origins are unknown end up on a service road in southern Alberta?

A similar question presented itself in 2013 when an Oregon farmer discovered a clump of wheat (although wheat is planted in rows) that turned out to be a genetically engineered herbicide-tolerant variety. It too contained an herbicide-tolerant gene from a Monsanto field trial. But the Oregon farmer had never taken part in the U.S. field trials, which in any case had been discontinued in 2005, eight years before the discovery. 

Like the recent Canadian experience, the unauthorized GE wheat was a different variety from that growing on the Oregon farm. Moreover, the glyphosate-resistant wheat in the Oregon farmer’s field was winter wheat, which is distinct from the white spring wheat in the years-earlier field trials, and Monsanto’s internal investigation found in any case that there was no “prior test site at the location where the material under investigation was reported to have been present.” Because the two varieties pollinate at different times, it is unlikely that the glyphosate-resistance trait was transferred by wind. That mystery was never solved.

Both investigations tested the machinery, wheat and farming practices and eliminated the farmers from having any involvement. In the Oregon case, the final verdict was that the seeds ended up in a fallow field by “accidental or purposeful mixing of seed.” [Emphasis added]

In both cases, the discovery of an unauthorized GE wheat caused significant trade disruptions. In the U.S. case, Monsanto ended up paying millions of dollars to compensate famers for their losses during the trade disruption. As a result of the discovery of the mystery Canadian GE wheat, Japan and South Korea have instituted bans on importation of all Canadian wheat. It is not known how long the present trade disruption will block Canadian wheat exports and how much financial hardship Canadian famers will suffer.

russian wheat333666777
Image Credit: Progressive Farmer

Super-sleuth Sherlock Holmes once observed, “When you have eliminated the impossible, whatever remains, however improbable, must be the truth.” And given that the evidence appears to rule out the mystery wheat having originated on either side of the border, we seem to be left with a verdict of intentional planting.

If that’s so, we must ask, cui bono? — who benefits from a disruption of Canadian wheat exports? An obvious candidate is Russia, the world’s largest wheat exporter and a major international mischief-maker where genetic engineering of crops is concerned.

But there are others who buy Canadian wheat. The discovery of GE wheat in Alberta caused an immediate drop in the price of Canadian wheat, and China is one of its biggest purchasers. Chinese nationals have been caught and convicted of stealing GE germplasm in the past, and China definitely has the technical expertise to create a novel GE wheat variety.

Environmental NGOs with anti-GMO campaigns are also prime candidates, and Greenpeace has a history of illegal anti-GMO actions. In 1995, the organization announced that it had “intercepted a package containing rice seed genetically manipulated to produce a toxic insecticide, as it was being exported . . . [and] swapped the genetically manipulated seed with normal rice.” [I. Meister, “Uncontrolled Trade in Genetically Manipulated Products,” press release, April 7, 1995].

Continued investigation should determine the source of the mystery wheat variety and help shed some light on how it suddenly appeared on a roadside in the prairie of southern Alberta.

Canadian farmers need answers. Let’s hope the CFIA finds them, and that those responsible get their comeuppance. 

Rob Wager is in the Department of Biology at Vancouver Island University. Follow him on Twitter @RobertWager1

Henry I. Miller, a physician and molecular biologist, is the Robert Wesson Fellow in Scientific Philosophy and Public Policy at Stanford University’s Hoover Institution. Follow him on Twitter @henryimiller

This article originally appeared at The Daily Caller as The Mystery of the ‘Rogue Wheat’ and has been republished here with permission.

Olympic gender confusion: Woman with too much testosterone required to take estrogen to compete while drug that blocks estrogen is banned

Sports Olympic Doping Alan Li JPG
Erik Lief and Chuck Dinerstein have each weighed in with companion pieces about a highly controversial rule by the International Association of Athletics Federations (I.A.A.F.), which governs international track and field competition.

[Editor’s note: This is the third in a three-part series on the complicated and fluid issue of gender and sexual identity in elite sports. Read part one and part two.]

South African Caster Semenya, a two-time Olympic champion in the 800 meters has unusually high levels of testosterone for a woman. While this no doubt plays some part in her success Semenya is not accused of doping; her body just makes more testosterone, which I.A.A.F. claims gives her an unfair advantage. So much so that they have established another classification female athletes called “differences of sexual development” (DSDs). The I.A.A.F established a maximum concentration of 5 nanomoles (a little more than a milligram) per liter (nM/L) of testosterone in blood for women who compete in the 400 m, 800 m, and 1,500 m events. The normal range in women is 0.12 to 1.79 nM/L.

At least they’re not being too unreasonable.

Athletes will not be required to undergo surgery to lower their hormone levels

I.A.A.F.

That leaves Semenya with three choices; not compete, compete against men, or take medication to lower her testosterone levels. It is the last of these that strikes me as rather strange. Should we be forcing athletes to take powerful medications to “correct” whatever advantage they were born with? And if so, there are certainly plenty of genetic advantages that determine size, strength, and endurance. Lung capacity is determined by both genetic and environmental factors and athletes with greater lung capacity will excel in sports like running and swimming. Michael Phelps has a lung capacity that is twice that of a normal man. Clearly, this gives him a competitive advantage, but is it unfair? Is the Phelps case all that different from the Semenya case? Is Semenya being required to take medicine because it is feasible while cutting out one of Phelps’ lungs is not? Where do we draw the line?

The powerful medicine that Semenya would need to take is hormone replacement therapy (HRT), which is used most commonly by women who are going through menopause and are experiencing unpleasant symptoms, such as hot flashes and also to fight osteoporosis.

There are two types of HRT–estrogen-only and estrogen plus progesterone. Estrogen plus progesterone is used in women who still have a uterus (have not undergone a hysterectomy) Semenya would be presumably taking estrogens to make herself “more female.”

Will HRT therapy for some period of time before a competition be harmful? Probably not. Young women with certain conditions are treated with the drugs. But this would be the first time an athlete would be required to take a drug to decrease performance.

And there is a bit of irony here. Cheating is an Olympic sport in the Olympics. This lead the International Olympic Committee to form the World Anti-Doping Agency (WADA) in 1999. WADA’s mission is to ensure that performance-enhancing drugs stay out of sports. The agency is rather strict about what to ban or limit, for example, asthma medications, diuretics, growth hormones, decongestants, and anti-inflammatory steroids (prednisone), to name a few.

And Tamoxifen, which blocks the action of estrogen. So, in track and field, a woman with too much testosterone is required to take estrogen to compete while in the Olympics it’s illegal to take another drug that blocks estrogen.

Pretty crazy, no?

Josh Bloom is the Senior Director of Chemical and Pharmaceutical Sciences at the American Council on Science and Health. Follow him on Twitter @JoshBloomACSH  

This article was originally published by the American Council on Science and Health as Women Athletes & Elevated Testosterone: A Pharmacological View, and has been reproduced here with permission.

FDA releases guidelines to fast-track new generation of fast-acting antidepressants

esketamine png

As companies race to develop fast-acting antidepressants, they are grappling with how to design clinical trials for a type of drug that doesn’t yet exist.

There’s no shortage of interest in the idea: Janssen (JNJ) is testing an esketamine nasal spray, which, when combined with an oral antidepressant, has shown promise in quickly curbing symptoms of serious depression.

…

Late last month, the FDA stepped in to offer some help. The agency released a draft guidance on developing new treatments for major depressive disorder that lays out the special considerations for clinical trials on rapid-acting antidepressants.

…

Current trial designs assume it’ll take four to eight weeks for a drug to kick in. But fast-acting antidepressants should, in theory, start working much sooner.

…

[T]he FDA said drug makers need to show that the drugs work within a week. And in the case of drugs that seem to work particularly quickly, an appropriate endpoint might be just hours after the first dose.

…

There’s also a question of determining the right dose — or doses. The FDA said it’s particularly interested in studies that test whether a lower dose of the drug than what’s needed for short-term efficacy can maintain the treatment response in the long run.

The new guidance offers drug companies insight into how the agency is thinking about this potentially new class of drugs.

Read full, original post: Companies are racing to develop fast-acting depression drugs — but the process is tricky

Viewpoint: There’s no one ‘butterfly-killing bogeyman’ to blame for declining monarch populations

N FF

“When you look at the 25-year trend, it seems quite dire,” [Anurag] Agrawal, a Cornell University professor of ecology and evolutionary biology and the author of Monarchs and Milkweed, says. “There has been a steep, persistent decline in the number of monarchs that overwinter in Mexico every year. But no one is arguing that the monarch butterflies are threatened or endangered as a species. What we are arguing is that the eastern North American migration, in which hundreds of millions of monarchs travel several thousand kilometers every year, is in serious trouble and may be lost.”

…

While a host of human factors are contributing to the stark decline in the number of monarchs overwintering in Mexico each year – some 20 million are thought to be killed by vehicles alone – the conventional wisdom for years has been that widespread herbicide use throughout great swaths of the United States has decimated milkweed, which is the only source of food for monarch caterpillars.

But simply pointing to herbicide use as the butterfly-killing bogeyman is oversimplifying a complex issue, Agrawal warns.

…

Agrawal thinks that the narrative is once again starting to change as scientists and non-scientists alike come to realize the true complexity of the problem. When a species has a life cycle as complicated as that of the monarch butterfly, which has four generations every year and faces a long and treacherous migration, it’s very difficult to put a relative importance to the various dangers it faces.

Read full, original article: No shortage of dangers’ and no easy answers for the monarch butterfly

Understanding the weird world of genes

genes

Pretty much everyone, at least in societies with access to public education or exposure to media in its various forms, has been introduced to the idea of the gene, but “exposure does not equate to understanding.”

…

Through his studies on peas, Gregor Mendel was the first to clearly identify some of the rules for the behavior of these inheritable factors using highly stereotyped, and essentially discontinuous traits – a pea was either yellow or green, wrinkled or smooth. 

…

Understanding such processes is critical to appreciating the fact that genetics is often not destiny, but rather alterations in probabilities…Without such an more nuanced and realistic understanding, it can be difficult to make sense of genetic information.

…

Genes are not static objects, but key parts of dynamic systems. This may be one reason that classical genetics, that is genes presented within a simple Mendelian (gene to trait) framework, should be moved deeper into the curriculum, where students have the background in molecular mechanisms needed to appreciate its complexities, complexities that arise from the multiple molecular machines acting to access, modify, and use the information captured in DNA (through evolutionary processes), thereby placing the gene in a more realistic cellular perspective.

Read full, original post: Genes – way weirder than you thought

Could commercial herbicides made from fungi bridge sustainability gap between organic and conventional agriculture?

EP

Nature is not just out to kill us, it is out to kill itself, in the interest of surviving over the long term. That is why even the most wholesome backyard organic garden is a hotbed of combat between plants and unseen microorganisms in the soil fighting for space to grow.

To defeat a plant, a microbe might produce and use toxic chemicals – but then the microbe also needs immunity from its own poisons. The genes that create protective shield in microorganisms could become a new, highly effective weed killer and the first new class of commercial herbicides in more than 30 years.

…

The new herbicide was discovered using resistance gene-directed genome mining – searching the genes of thousands of fungi for one that might provide immunity against fungal poisons.

…

The new herbicide acts by inhibiting the function of an enzyme that is necessary for plants’ survival. The enzyme is a key catalyst in an important metabolic pathway that makes essential amino acids. When this pathway is disrupted, the plants die.

To confirm the efficacy of the new herbicide, the team tested the fungus-produced product on a common plant used in lab studies…the product killed the plants after they were sprayed with it. The researchers also implanted the resistance gene from the fungus into [the plant’s] genome. The plants that had the resistance gene implanted in them were immune to the herbicide.

…

Pests of all kinds have always struggled to keep up with science, so even the best product will lead to resistance…A natural weed killer satisfies the organic camp and the science one.

Read full, original article: New Class Of Commercial Herbicide Is All Natural – But Discovered Using Science

Public sorting through what labels shoppers want on sustainable, lab grown meat, Consumer Reports finds

Beyond Meat Vegan Food

Consumer Reports, published by the 7 million-member nonprofit Consumers Union, [recently] reported on survey results showing the public expects laboratory-produced meat from cultured animal cells to be clearly labeled. The results show the public favors different language [than] those pushing the new products.

“By an overwhelming margin, our survey found that consumers want clear labels identifying meat produced in the lab from cultured animal cells,” said Dr. Michael Hansen, senior scientist for Consumers Union, the advocacy division of Consumer Reports.

“Federal regulators should ensure these emerging food products are clearly labeled so consumers can make informed choices for their families and easily distinguish them from conventional meat.”

The Consumer Reports phone survey found that 49 percent said it should be labeled as “meat, but accompanied by an explanation about how it is produced,” while another 40 percent said it should be labeled as “something other than meat.”  

…

Investors in the new lab-meat are said to include traditional meat industry giants Tyson and Cargill along with billionaires like Bill Gates and Richard Branson. One lab-grown hamburger created in 2013 was said to have cost $300,000. The first pricy lab-grown meat could reach the market in about three years.

Read full, original article: Public overwhelmingly favors term ‘lab-grown’ over ‘clean’ meat

Gene drives could speed up inheritance of certain beneficial traits in mammals, study finds

F large

Researchers have used CRISPR, the genome editing tool, to speed the inheritance of specific genes in mammals for the first time. Demonstrated in lab-reared insects several years ago, this controversial “gene-drive” strategy promises the ability to quickly spread a gene throughout an entire species. It has sparked dreams of deploying lethal genes to eradicate pests such as malaria-carrying mosquitoes—and now, perhaps, crop-damaging, disease-causing mammals such as rabbits, mice, and rats.

The new research aims to create novel strains of lab mice, not wipe out wild populations, and it shows that gene drives work less efficiently in rodents than in insects.

…

[The] researchers built their gene drive by engineering female mice to carry the gene for the DNA-cutting enzyme Cas9, one of CRISPR’s two components; they engineered males to carry a gene for the other component, the guide RNA (gRNA) that shuttles Cas9 to a specific target on a genome, plus a gene that modifies coat color. Breeding the altered mice created pups that had the genes for both CRISPR components on different chromosomes.

…

[I]n females, the gene drive succeeded. It copied the coat color modifying gene to the partner chromosome in many eggs.

…

[Researcher Kimberly] Cooper and her colleagues write that this system of “active genetic elements” could speed the creation of mice that have several introduced or crippled genes.

Read full, original post: ‘Gene drive’ passes first test in mammals, speeding up inheritance in mice

Can we delay aging by killing off old cells with powerful drug combo?

aging

We have a good idea of what makes individual cells old. Things like DNA damage, shortened chromosome ends, and a lack of proliferative ability can all cause cells to basically shut down—they don’t die, but they stop dividing and become quiescent. But we don’t have a strong sense of what makes an organism old. It could be the cumulative effect of lots of their cells getting old, or there may be additional means of registering an organism’s age.

Now, a new study suggests at least part of the answer may be a mix of the two. The study, done using mice, indicates that having a small population of cells that have hit the wall due to aging can induce symptoms of age-related decline in otherwise young mice. And a drug combination that targets these [senescent] cells can block these problems from taking root. The same drugs, when given to elderly mice, also reduce mortality and limit some of the symptoms of age.

…

Could this work in humans? There’s a hint that it might. The researchers obtained fat from obese people in for surgery; this normally contains senescent cells. The researchers confirmed that treating the fat with these chemicals reduced the number of senescent cells present.

…

[However], while senescent cells may be part of the picture, they’re far from the whole story on aging.

Read full, original post: Drugs that kill off old cells may limit a body’s aging

Viewpoint: CRISPR gene editing might quell ‘frankenfood’ fears and win consumer support for biotech

GetStoredImage

The debate surrounding genetically engineered (“GE” or “GMO”) plants and animals has historically been, and still is, extremely divisive. Anti-GMO activists raise many objections, including two that often resonate with a segment of the public: (1) control of the food supply by a few multinational corporations, and (2) reliance on pesticides.

…

But what if modern biotechnology could take those two objections out of the debate, as well as directly benefit consumers? Would there be greater consumer acceptance? A new generation of agricultural products that are being created through gene-editing techniques, such as CRISPR and TALENS, certainly have the potential to accomplish that.

Gene editing is cheaper and easier to use than genetic engineering, so academic scientists and new startup biotechnology companies, in addition to multinational corporations, have begun to use these technologies to make new varieties of crops and animals with useful traits. Many gene-edited products in the commercial pipeline are not linked to pesticides and have unique traits that could be of interest to consumers.

…

If they get to market and consumers recognize the benefits they provide, then gene-edited crops and animals could be the spark to bridge the divide in the GMO debate.

Read full, original article: Gene-Edited Plants and Animals: Can They Bridge the Divide in the GMO Debate?

Video: Why having a dog can put you in a ‘state of calm’

o

Your pets have a larger effect on your body and brain than you might think. They have the ability to increase levels of oxytocin in the brain, bringing you a state of calm. Following is a transcript of the video.

Narrator: Puppies, they’re the furry friends we take for granted. But, how does having one affect us?

Meg Olmert: My name is Meg Olmert and I’m the author of “Made For Each Other: the biology of the human-animal bond.”

…

Olmert: There is a feedback system that both neurochemically and psychologically and behaviorally that sets up between you and your pet. And how good you are to your pet is often exactly reflected back.

…

[A] mother will have certain brain regions light up very strongly in the dopamine and oxytocin rich areas when they look at a picture of their baby versus just another infant. When you look at a picture of your dog versus another dog, you see the same thing.

…

Narrator: What happens to your body when you’re with your dog?

Olmert: Your heart rate comes down, your blood pressure comes down, your heart rate variability which is the ability of the heart to duck and dive and respond to stress improves. You release oxytocin, the opioids, adrenaline, and serotonin. So, all of these great reward chemicals and anti-stress chemicals can be released.

Read full, original post: What having a dog does to your brain and body

German Agriculture Minister warns against ‘reflexive’ rejection of nutritional and safe CRISPR gene editing-created crops and foods

greenpeace europe

Federal Agriculture Minister Julia Klöckner has warned against a “reflexive” rejection of the use of [new breeding techniques, or NBTs] in agriculture. “We must be careful that we do not refuse [technological] progress because we have an abundant supply of food. The technology could save lives in other regions of the world,” she said on [July 14th]. New breeding methods could, for example, help crops survive in regions where the soil is too dry.

Klöckner demanded more transparency about food and agriculture at the same time, noting that providing information does no harm to anyone. The topic causes consumers discomfort because they do not fully understand how technological innovation is changing food production.

…

The European Court of Justice (ECJ) will review [NBTs] on July 25th. The court will clarify whether certain new [plant breeding] methods will be exempted from Europe’s strict rules on genetic engineering, and evaluate licensing procedures and labeling requirements.

Editor’s note: This article was originally published in German. This English summary has been prepared with Google Translate and lightly edited for clarity.

Read full, original article: Klöckner gegen reflexartiges Nein zu Gentechnik bei Lebensmitteln

Viewpoint: If Ghana embraces GMOs, farmers could save nation’s floundering agricultural sector

maize farmers dayjpg

Ghana has prided itself over the years with agriculture being the key backbone of its economy. But for a long time, we have continued to rely on hoe and cutlass, traditional seeds and traditional methods to grow the food we eat. Yet, we continue to hope for a transformation of the [agricultural] sector.

…

I’m of the opinion that Ghana is sitting on a time bomb with regards to food sufficiency and security, especially with the recent trend and occurrences like the rise of the Fall Army Worms which affected over 110,000 hectares of farm fields in 2017, forcing government to invest [heavily in] chemicals to control them.

…

[F]igures show that from 2009 to 2017, the contribution of the agriculture sector to the GDP took a whooping decline from 31.8% to 19.0%. Worst of all, from just 2011 to 2014, the contribution of the sector declined from 29.8% to 21.5%.

…

As a farmer, I am much worried about the fact that all the pragmatic measures President Akufo-Addo and his government are putting in place to raise the standard of agriculture in Ghana might come to naught if we fail to take seriously and fast track the processes leading to the approval of GMOs in Ghana.

Read full, original article: Delay In Approving GMOs In Ghana Is The Highest Form Of Injustice To The Ordinary Ghanaian Farmer

Defining gender and questioning the need for a ‘level playing field’ in elite athletics

Dutee Chand
The context surrounding the study of the impact of testosterone on elite athletes is essential in understanding its underlying hypothesis – that “excess” endogenous testosterone confers a competitive advantage. This is a direct outgrowth of the Dutee Chand suspension.

[Editor’s note: Dutee Chand is one of the world’s top sprinters and current Indian national 100-meter champion. Her success is linked in part to a genetic anomaly–she has hyperandrogegism, a mutation that results in higher testosterone levels. There is no suggestion that she illegally ‘doped’. But her usually high hormone level led to her being suspended from the 2014 Commonwealth Games.]

Chand’s suspension was overturned, pending more research and a further ruling from international sports authorities, because while “possessing high levels of testosterone and thereby increasing lean body mass creates a competitive advantage,” there was no evidence of endogenous testosterone’s impact. It also explains the apparent conflict of interest of the authors; one the head of the International Association of Athletics Federation (IAAF) Health and Science Department, the other a consultant and member of the workgroup on hyperandrogenic females and transgender issues and was a witness in the Chand case.

While exogenous testosterone and androgens are among the most commonly used doping substances of female athletes accounting for 55% of 116 females serving under a doping ban in 2016, the issue at hand is endogenous production – that is, elevated levels of testosterone and androgens made naturally by these athletes because of their innate metabolomics, characterized as hyperandrogenic “disorders.”

[Editor’s note: This is the second in a three-part series on the complicated and fluid issue of gender and sexual identity in elite sports. Read part one and part three.]

The Study

21 female and 22 male elite athletes participating in the 2011 and 2013 IAAF World Championships in track and field form the basis of the study. The researchers utilized 1332 observations of women 795 of men based on completion of an event as a solo performer with a complete blood panel. Blood was collected after being on site for at least 24 hours and at least 2 hours after intense exercise. The best performance during the competition was used for the performance benchmark.

Results

Among the female elite athletes, there were 44 observations in which free testosterone was greater than 3.08 nmol/L placing them in the 99thpercentile among elite female athletes. It should be noted that of the 18 female athletes identified half were found to be doping and for an additional six it was unclear whether the free testosterone levels were endogenous or exogenous.

Dutee_Chand55532123
Dutee Chand. Image Credit: Wikipedia

The performance data for all 18 were used raising the question of whether this data accurately reflects the performance of women like Chand or Caster Semenya. These clearly elevated levels were identified in two areas running and throwing. Of the 21 track and field events, a statistical difference in times or distances was noted in the 400 and 800m, the 400m hurdles, pole vault, and hammer throw when comparing those athletes in the highest quartile to those in the lowest. This represented a 2.73%, 2.78%, and 1.78% faster time in running events and 2.94% and 4.53% greater distances for the vault and hammer respectively. When compared to all of the elite runners, and you might argue that this was a better measure of their “advantage” the improvements were generally half as much.

Among the male elite athletes, 101 or about 13% had significantly decreased levels of free testosterone (<0.23nmol/L), and they participated in all events except for sprints and combined events. There was “no significant difference in performance” noted in the men.

Discussion

“Our study design cannot provide evidence for causality between androgen level and performance, but can indicate associations….” The researchers first considered the effect of testosterone on hemoglobin production which improves performance by increasing energy production. They found about a 0.6g/100mL difference in hemoglobin levels based on the highest and lowest free testosterone quartiles, but this difference in hemoglobin did not impact speed in the three running events they considered. Consequently, they concluded that free testosterone “concentration is a stronger determinant of performance in the 400 m, 400 m hurdles and 800 m than Hb [Hemoglobin] concentration.”

They also felt that androgens might influence lean body mass as well as “mental drive and aggressiveness” none of which they quantify, which is reasonable given that ambiguity of such a quantification. What is not reasonable is including other readily measured qualities that enhance performance, most importantly the body height and mass. There is significant evidence based upon mechanics of the advantages of both of these factors.

In discussing the pole vault and hammer throw, the narrative of an enhancing effect of testosterone breaks down. First, there is no ready or plausible explanation for the greater vaulting height beyond greater strength, but this did not hold true for other events like shot put or javelin. To provide a reason an advantage in the hammer throw, the authors pointed to the rotation required before the toss and its associated “mental rotation task” which they indicate is greater under the androgenic influence.

A deeper dive into that particular statement shows that the mental rotation task was to identify whether a visualized object had been rotated not whether the participants recognized their spatial orientation after being rotated a task more closely aligned with the hammer throw than recognizing whether the hammer has rotated in your hand. Finally, they concluded that the lack of difference in male performance, when stratified by free testosterone, suggested that women had more ”to gain in muscle mass and strength.”

To summarize, some of the data used reflected exogenous, not endogenous free testosterone, a difference in outcomes was found in only some, not all of the events so that a plausible underlying physiologic mechanism is not clear and physical differences that might account for outcomes were not taken into account. Do you believe that this is sufficient evidence that free testosterone confers a competitive advantage requiring chemical “correction” to level the playing field?

I think one of the main controversies coming out of the discussion surrounding Caster Semenya is the definition of gender. If you look historically, you can see the progression in our thinking.

Initially, gender was defined phenotypically, by one’s anatomy. Either you were male or female, and there was a small group of others labeled hermaphrodites. Fast forward centuries but to less than a century ago, in 1923, when the work of Mendel lead to the discovery of our “sex” chromosomes, the X and Y of life; gender could now be defined genetically,  XX or XY. Of course, again that lead to the discovery of other genetic versions, like XXY.  In reality, the determination of male and female doesn’t require the entire Y chromosome, just one gene, SRY. And SRY has been found in individuals we would consider women.

sry gene
Image Credit: Easy Notecards

The IAAF has moved the definition once again, away from chromosomes and genes, gender is now to be based on metabolic activity. It is not that these athletes are not phenotypically or genetically what we have considered female, but that our measurements can now detect differences in metabolic behavior.

Of course, interacting with all of these science-based definitions are cultural ones that we have confused and conflated with one another. From my view, defining gender based on overall metabolism, the metabolome, is too fine a distinction and serves us poorly in clinical care. Altering the definition of gender in this way means that we have to test for gender in doing observational and randomized studies, we cannot simply decide by self-reported phenotype.

Finally, who said that athletics, especially at the elite level, occurs on a level playing field? As I wrote in the review of the IAAF’s study, no one accounted for height. If we are going to flatten the field for metabolism certainly height and muscle mass, the real target of those testosterone-concerns, confer an unfair advantage. Are we going to have the short stretched or the tall shortened in a new version of the Procrustean Bed? Whatever advantage, if any, these athletes have, it was randomly assigned, and they should not be penalized.

They certainly should not have to take drugs to change their metabolism to meet the definitions of the IAAF, a group of 27 elected members where “there is guaranteed a minimum of six female members.” Is 22% equitable representation? And by the way, when the IAAF talks about its board in this way do they mean the board’s genetics or their metabolism?

Dr. Charles Dinerstein, M.D., M.B.A., F.A.C.S. is senior medical fellow at the American Council on Science and Health. Follow him on Twitter @CRDtoday.

This article was originally published by the American Council on Science and Health as The Effect Of Endogenous Androgens In Elite Female Athletes, and has been reproduced here with permission.

Why we don’t all need to be vegans in the pursuit of sustainability

cattle
Humans are unique in the degree to which they can manipulate their surroundings. And agriculture is one enormous way to do that manipulating — triggering fierce arguments over the impact on the planet. So, when an Oxford University study was published in Science looking at the sustainability of farming and ranching practices, it was heralded with curious reactions.

“Avoiding meat and dairy is the single biggest way to reduce your impact on earth,” read a headline in the UK Guardian, introducing the study published in Science by Joseph Poore, a zoology professor at Oxford, and Thomas Nemecek, a scientist at LCA Research Group in Zurich, Switzerland. Further, the Guardian quoted Poore as saying “A vegan diet is probably the single biggest way to reduce your impact on planet Earth, not just greenhouse gases, but global acidification, eutrophication, land use and water use.”

Poore’s study did indeed study GHGs, acidification, eutrophication, land and water use. But the paper does not conclude a recommendation of veganism. Instead, it calls for producers to monitor impacts, and find different ways to produce foods.

The study was a meta-analysis, a review of 570 studies of 38,700 farms and 1,600 processors, packagers and retailers. It found that agriculture has a massive impact on the planet—meat and dairy provide 18 percent of calories and 37 percent of protein, while using 83 percent of all farmland and generating 60 percent of agriculture’s greenhouse gas emissions. And it did look at the impacts on five environmental criteria according to production methods. But oddly, the paper’s conclusions—and the media pickup—focused on greenhouse gas emissions.

Poore’s study showed huge variations in production methods. Beef cattle raised on deforested pasture produced 12 times more greenhouse gas and used 50 times more than beef raised on natural pasture. And beef produced six times more greenhouse gases and 36 times more land than raising protein from peas, for example.

One method was grass-fed beef, introduced because it was considered more humane and ecological sustainable than other methods of feeding livestock.

And people who have long opposed eating meat picked up on the story. George Monbiot, a writer and environmental activist in the UK, tweeted that “the food campaigners meant well but got it wrong: switching from intensive meat to free range meat means less cruelty but even greater environmental destruction. The switch should be to a plant-based diet.” In a video, Monbiot expands on his case:

[youtube https://www.youtube.com/watch?v=mm-MpiFYpAQ&w=535&h=315]

So, is all meat not only murder but murderous to the planet? Is veganism the only path to ecological sustainability?

Not so fast, according to UC Davis animal geneticist Alison Van Eenennaam. “Sustainability” will depend on what variable you are optimizing—is it greenhouse gas? Land use? Acidification? Cruelty? Productivity? They don’t always point in the same direction, she warned.

“The best solution is always a more efficient production system like the US,” Van Eenennaam said in an email interview with the Genetic Literacy Project. “And the use of technologies like implants and ionophores, which of course everyone freaks out about.” These technologies involve:

  • Growth promoting implants, such as growth hormones, that have been used for almost 50 years to improve growth rates by 10-30 percent, feed efficiency by 5-15 percent, and meat leanness by 5-8 percent). However, growth hormones and other implants have been criticized for being “unnatural” and possibly risky to health.
  • Ionophores, feed additives that alter how food is fermented and ultimately digested in the cow’s rumen and improve conversion of feed to lean muscle mass. Although ionophores are not “true” antibiotics because don’t outright kill bacteria but inhibit bacterial function, they have come under fire because of overall public concerns about antibiotics in the food supply.

So far, technologies like genetic engineering have not yet been approved in cattle and nearly all livestock and may be unlikely to play a role given opposition from powerful non-governmental organizations.

A chart of productivity among different countries livestock from a “Dietitians’ Handout” by Van Eenennaam does point to a great deal of variability. Countries like the United States — and to a lesser degree, China — do show greater tonnage of meat from a given number of cattle. Others, like India, Ethiopia and Sudan, show dramatically less productivity.

Another study, by Ray Hilborn of the University of Washington, and his colleagues, compared the environmental cost of animal foods in more detail and found wild, wide variations:

  • Greenhouse gas production was lowest in mollusk farming and smaller pelagic fisheries (salmon farming, white fish) and chicken, while catfish farms and beef were 20 times higher in GHG production.
  • Energy use was lowest in mollusk and small pelagic fisheries, but livestock was still lower than all other types of aquaculture (beef required less energy than shrimperies, for example).
  • Eutrophication was lowest in pelagic fisheries and mollusk and salmon farms, but higher in catfish and beef operations, though beef showed an extremely broad range of eutrophication.
  • Acidification potential was lowest for mollusks, and small pelagic, white fish and salmon farms at the lower level. Beef production had the highest acidification impact, mostly due to (again) high variability among beef production studies.

“There are striking differences in terms of the environmental impacts of different animal source food production methods,” Hilborn and his colleagues wrote. “Because the range of variability is quite high, any proposed policy must consider the specific species and production system.”

Another point Van Eenennaam makes is that removing cows from fields does not necessarily result in improved sustainability. Instead, it leaves a fallow field, full of plant matter that is inedible to us, that must be re-sown. Even some plants do not get off the hook. Asparagus, for example, consumes a dramatic amount of fossil fuels, and therefore emits far more carbon dioxide, because of requirements to transport the vegetable to markets.

Instead of veganism, looking at the best way to get a gram of protein might point to true sustainability. Protein—especially animal protein—is the easiest way for developing countries to raise living standards, by providing enough to eat more cheaply. However, a cow raised one way can be more sustainable than a cow raised another way. All food production involves tradeoffs; optimizing product quality and safety, improving animal welfare, and decreasing impact on the environment and using natural resources efficiency all require reducing one in favor of another.

There’s no free lunch.

Andrew Porterfield is a writer and editor, and has worked with numerous academic institutions, companies and non-profits in the life sciences. BIO. Follow him on Twitter @AMPorterfield.

‘Scientific gold rush’ created by quest for universal immunotherapy

cancer immunotherapy birak

The drug industry has made a mint on immunotherapies for cancer, but those game-changing treatments don’t work for most people’s tumors. That has set in motion a scientific gold rush, as biotech companies search for molecules they can add to those drugs to turn them into universal therapies.

The latest promising candidate is TGF-beta, a thorny collection of proteins that regulates a host of bodily functions. Among them is the process by which the immune system decides to either attack cancerous growths or let them pass idly by.

Early data suggest that adding a drug that blocks TGF-beta to blockbuster cancer treatments like Merck’s Keytruda and Bristol-Myers Squibb’s Opdivo could help vanquish tumors.

…

[R]esearchers have learned the hard way that making products out of a winning idea is more complicated than simply cooking up a targeted drug. TGF-beta is not a discrete target but rather what scientists call a superfamily.

…

Choose too few targets and your drug is likely to have no effect, but target TGF-beta indiscriminately and you risk attacking innocent proteins and running into damning toxicities, said John Quisel, [chief business officer at Acceleron Pharma].

…

“Our approach is that you have to have what I’ll call leavened activity against the right group of targets in order to find a balance on that spectrum between safety and activity,” Quisel said.

[Editor’s note: Full text is behind paywall]

Read full, original post: Biopharma has a new big idea for making cancer immunotherapy work better

Sri Lankan government lifts glyphosate ban to aid tea growers ‘plagued’ by weeds, slumping production

The [Sri Lankan] government has lifted [a two-year] ban on glyphosate for all crops throughout the country.

…

The Government imposed the glyphosate ban in 2015 over fears that this chemical was one of the causes of the kidney disease epidemic in the North-Central Province and elsewhere. In the absence of an effective alternative [herbicide], however, the tea industry in particular was severely hit, with plantations becoming plagued by weeds, and resulting in a drastic drop in production.

In March, Plantation Industries Minister Navin Dissanayake told the Sunday Times that the industry had faced a crop loss of [over $100,000,000] …due to the glyphosate ban.

…

Nevertheless, moves to lift the ban, even in limited form, has drawn flak from certain quarters, including those in the Government, with Health Minister Rajitha Senaratne and independent MP Ven. Athuraliye Rathana Thera being particularly vocal in their opposition to such moves.

Read full, original article: Glyphosate ban lifted

FDA vs USDA? Federal agencies ready for a turf war, but may partner to regulate lab-grown meat

cultured meat gty er hpMain x

FDA Commissioner Scott Gottlieb said [on July 17th] that the agency is working closely with USDA on early efforts to establish a regulatory framework for lab-grown meat, or “cell-cultured foods,” the FDA’s preferred name for it.

The budding technology involves replicating animal cells to create foods like burgers and seafood. It has set up a turf battle between the FDA and USDA because both have authority over food safety rules.

…

“We’re working closely with USDA to try to understand what, if any, jurisdictional lines there are to know what role [the department] would play potentially in this as well,” Gottlieb said. “But it’s very clear to us that a lot of the scientific aspects of this is what [FDA] is going to be looking at, and certainly things like fish would fall squarely within our domain.”

…

Gottlieb said there may be collaborative efforts with USDA on meat and poultry, but a lot of the cell-cultured products will likely be outside that sector.

Read full, original article: Gottlieb: FDA working closely with USDA on jurisdiction over ‘cell-cultured foods’

Is our genome altered by things that happen to us as children?

TarahPhotography Newborn San Francisco Hercules
[A] new study makes a remarkable connection between experience and the genetic diversity of the brain. It suggests that experience can change the DNA sequence of the genome contained in brain cells.

…

The care that a newborn receives in early life can have profound effects on psychological and intellectual growth.  Attentive nurturing, feeding and grooming can reduce stress and anxiety and enhance psychological wellbeing.  On the other hand, indifference can lead to increased anxiety and impaired psychological adjustment.  This study reveals that one way the quality of early care could cause lifelong changes in behavior is by changing the brain’s genetic nature.

In this study researchers identified natural differences in the quality and abundance of maternal care provided by mice based upon measures of time they spent grooming and nursing their pups.  They identified groups of animals that provided either high or low maternal care.

…

Mobile genetic elements accumulated in specific regions of the brains of mouse pups if the pups had poor maternal care. If a pup was born to a mother animal that provided low maternal care, but raised by a mother animal that provided high maternal care that accumulation of mobile genetic elements was eliminated.

…

[Therefore, childhood mistreatment] may genetically predispose an individual to neurological or psychiatric disease even in the absence of any family history of such disease.

Read full, original post: Early Life Experience: It’s in Your DNA